Equity Plans

As of June 1, 2017, 100 million shares were available for future awards under our equity plans.

Stock Options



	Quarter ended						Nine months ended
	June 1, 2017			June 2, 2016			June 1, 2017			June 2, 2016
Stock options granted	1			1			7			8
Weighted-average grant-date fair value per share	$	11.64		$	4.92		$	8.59		$	6.96
Average expected life in years	5.5			5.6			5.5			5.5
Weighted-average expected volatility	44		%	51		%	46		%	47		%
Weighted-average risk-free interest rate	2.0		%	1.3		%	1.8		%	1.7		%
Expected dividend yield	0		%	0		%	0		%	0		%

Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")



	Quarter ended				Nine months ended
	June 1, 2017		June 2, 2016		June 1, 2017		June 2, 2016
Restricted stock awards granted	—		—		8		9
Weighted-average grant-date fair value per share	$	27.75	$	10.35	$	19.10	$	15.75

Stock-based Compensation Expense



	Quarter ended				Nine months ended
	June 1, 2017		June 2, 2016		June 1, 2017		June 2, 2016
Stock-based compensation expense by caption
Cost of goods sold	$	24	$	21	$	66	$	58
Selling, general, and administrative	20		14		53		52
Research and development	13		12		39		38
	$	57	$	47	$	158	$	148

Stock-based compensation expense by type of award
Stock options	$	19	$	19	$	54	$	61
Restricted stock awards	38		28		104		87
	$	57	$	47	$	158	$	148

As of June 1, 2017, $402 million of total unrecognized compensation costs for unvested awards was expected to be recognized through the third quarter of 2021, resulting in a weighted-average period of 1.2 years. Stock-based compensation expense does not reflect significant income tax benefits, which is consistent with our treatment of income or loss from our U.S. operations.